SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Indaptus Therapeutics, Inc. (INDP) News

Follow Indaptus Therapeutics, Inc. (INDP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol INDP Asset equity Sector Markets 90 days 8 Last 2.81 Updated Nov 16, 2026, 02:37 PM UTC Open live news feed Open INDP chart & news
M Rapid Micro Biosystems Misses Q3 Revenue Estimates, Withdraws FY Outlook Rapid Micro Biosystems reported Q3 revenue below estimates and withdrew its fiscal-year outlook. EQUITY | Nov 16, 2026, 02:37 PM UTC M Indaptus Therapeutics Reports $5.4 Million Nine-Month Loss Indaptus Therapeutics reported a net loss of $5.4 million for the first nine months of 2026, down from $12.7 million a year earlier. Third-quarter net loss was $1.0 million versus $3.0 million a year earlier. EARNINGS | Nov 13, 2026, 09:34 PM UTC M Highway Holdings Closes $7 Million Investment, Plans Legacy Business Spin-Off Highway Holdings said existing shareholders will receive its legacy manufacturing business through a pro rata spin-off. EQUITY | Nov 05, 2026, 12:02 PM UTC L MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better Moderna, Inc. (MRNA) is on track to become September’s second-best performer in the S&P 500, but five smaller stocks have delivered even larger gains this month, driven by developments ranging from an impending ALS trial EQUITY | Sep 25, 2026, 03:24 AM UTC H Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday U.S. stocks were lower, with the Dow Jones index falling around 300 points on Tuesday. Shares of Radiant Logistics Inc (NYSE: RLGT ) rose sharply after the company reported better-than-expected fourth-quarter financial r LIVE | Sep 15, 2026, 01:53 PM UTC M Indaptus Therapeutics raises about $24.0 million in private placement Indaptus Therapeutics entered a stock purchase agreement for a private placement of 20,338,974 common shares, expected to generate about $24.0 million in gross proceeds. Shares are priced at the Nasdaq Minimum Price plus EQUITY | Sep 10, 2026, 10:13 AM UTC L Indaptus board member Tim Ruan resigns effective immediately Indaptus Therapeutics director Tim Ruan resigned from the board, effective immediately. REGULATION | Sep 04, 2026, 08:15 PM UTC L Indaptus Therapeutics launches $100 million ATM equity program Indaptus Therapeutics entered an amended and restated at-the-market offering agreement for flexible equity access, allowing sales of up to $100 million of common stock. H.C. Wainwright acts as sales agent and potentially EQUITY | Sep 01, 2026, 11:34 AM UTC L BXP prices $700 million senior unsecured notes offering BXP prices a $700 million offering of senior unsecured notes, according to the wire item. MNA | Aug 18, 2026, 09:14 AM UTC L Indaptus Therapeutics reports Q2 2026 results; issues corporate update Indaptus Therapeutics (INDP) reports its second quarter 2026 financial results and provides a corporate update, according to TradeXchange Newsdesk. EARNINGS | Aug 13, 2026, 11:00 AM UTC M INDP Sells 20M Shares Indaptus Therapeutics enters stock sale agreement to sell 20M shares for $0.06/share, expecting $12M in gross proceeds EQUITY | Jun 24, 2026, 08:07 PM UTC